Reuters logo
BRIEF-ARCH BIOPARTNERS INITIATES MANUFACTURING PROCESS FOR METABLOK
October 10, 2017 / 10:50 AM / in 2 months

BRIEF-ARCH BIOPARTNERS INITIATES MANUFACTURING PROCESS FOR METABLOK

Oct 10 (Reuters) - Arch Biopartners Inc:

* ARCH BIOPARTNERS INITIATES MANUFACTURING PROCESS FOR METABLOK

* ARCH BIOPARTNERS - ENGAGED CSBIO TO BEGIN MANUFACTURING PROCESS FOR METABLOK DRUG CANDIDATE FOR TREATING INFLAMMATION, CANCER METASTASIS AND SEPSIS​

* ARCH BIOPARTNERS INC - ‍ARCH IS PLANNING A PHASE I HUMAN TRIAL TO EVALUATE METABLOK‘S SAFETY AND PHARMACOKINETIC PROFILE​

* ARCH BIOPARTNERS INC- ‍INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO U.S. FDA IS CURRENTLY BEING PREPARED BY METABLOK TEAM FOR SUBMISSION IN 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below